No phaseCompleted
A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.
- Sponsor
- Vedic Lifesciences Pvt. Ltd. (Industry)
- Enrolment
- 104 enrolled
- Conditions
- Pre Diabetes; Type2 Diabetes Mellitus
- Interventions
- IP 1200 mg per soft gel capsule; Placebo Comparator: Placebo 1200 mg per soft gel capsule
- Ages
- adults, older adults
- Registry
- NCT06496893
Full record on ClinicalTrials.gov
From the registry
A randomized, double-blind, placebo-controlled study to assess the effect of Glucocil® on metabolic health in individuals with prediabetes and Type 2 Diabetes Mellitus.
Primary outcomes
- Cohort 2- (Type 2 diabetes mellitus (T2DM)) To assess the effect of Investigational Product (IP) on blood sugar as assessed by Glycated haemoglobin (HbA1c) in individuals with Type 2 diabetes mellitus (T2DM).
History
Last registry update
Primary completion
Started
Registered